It is noteworthy that, in this same study, the authors also showed that these patients have decreased HOMA-β, indicating lower insulin secretion capacity, justifying a higher percentage of patients with glucose intolerance when compared to the control group. The gene discussed is INS; the disease is Glucose intolerance.